Primary angiitis of the central nervous system has until recently been considered rare, usually
progressive, and untreatable. In 1987, preliminary diagnostic criteria for the disorder were …

Society of Neuroradiology, and the Foundation of the American Society of Neuroradiology
sponsored a series of working group meetings> 12 months, with the final meeting occurring …

Background The comparative effectiveness of percutaneous closure of patent foramen ovale
(PFO) plus medical therapy versus medical therapy alone for cryptogenic stroke is uncertain…

Background The prevalence of patent foramen ovale among patients with cryptogenic stroke
is higher than that in the general population. Closure with a percutaneous device is often …

Background The effect of endovascular thrombectomy that is performed more than 6 hours
after the onset of ischemic stroke is uncertain. Patients with a clinical deficit that is …

Background and Purpose— The National Institutes of Health (NIH) estimates that stroke costs
now exceed $45 billion per year. Stroke is the third leading cause of death and one of the …

Background and Purpose—To test the safety and recanalization efficacy of intra-arterial
local delivery of plasminogen activators in acute ischemic stroke, a randomized trial of …

Background and Purpose— Desmoteplase is a novel plasminogen activator with favorable
features in vitro compared with available agents. This study evaluated safety and efficacy of …

An open angiography‐based, dose rate escalation study on the effect of intravenous infusion
of recombinant tissue plasminogen activator(rt‐PA) on cerebral arterial recanalization in …

… 1 Adams HP Jr, Brott TG, Crowell RM, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Marler
JR, Woolson RF, Zivin JA, Feinberg W, Mayberg M. Guidelines for the management of patients …